Estimation of the infectious viral load required for transfusion‐transmitted human T‐lymphotropic virus type 1 infection (<scp>TT</scp>‐<scp>HTLV</scp>‐1) and of the effectiveness of leukocyte reduction in preventing <scp>TT</scp>‐<scp>HTLV</scp>‐1

Abstract

The residual number of HTLV-1-infected cells after LR is substantially lower than the viral load necessary for TT-HTLV-1. LR therefore appears to be effective in minimizing the incidence of TT-HTLV-1.